Citations

Mayo Clinic

Showing 10 of 108599 citations.

Combining Prostate Specific Antigen with Cancer and Gland Volume to Predict More Reliably Pathological Stage: The Influence of Prostate Specific Antigen Cancer Density
Blackwell, Kimberly , Bostwick, David G., Myers, Robert P., Zincke, Horst, Oesterling, Joseph E.

Journal of Urology | June 30, 2017 | Volume: 151 | Issue: 6 | Pages: 1565-1570

10.1016/s0022-5347(17)35303-x | PMID 7514689 Get It

Re: The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic Carcinoma, by M. K. Brawer, E. A. G. Aramburu, G. L. Chen, S. D. Preston and W. J. Ellis, J. Urol., 150: 369-373
Jacobsen, Steven J. , Oesterling, Joseph E., Guess, Harry A.

Journal of Urology | June 30, 2017 | Volume: 151 | Issue: 5 | Pages: 1356-1356

10.1016/s0022-5347(17)35256-4 | PMID 7512666 Get It

Prostate Specific Antigen Cannot Distinguish Stage T1a (A1) Prostate Cancer from Benign Prostatic Hyperplasia
Monda, Jeffrey M., Oesterling, Joseph E., Barry, Michael J.

Journal of Urology | June 30, 2017 | Volume: 151 | Issue: 5 | Pages: 1291-1295

10.1016/s0022-5347(17)35234-5 | PMID 7512660 Get It

Letter by Freeman Regarding Article, “Baseline Blood Pressure Effect on the Benefit and Safety of Intra-Arterial Treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands)”
Freeman, William D. , Freeman, William D

Stroke | June 30, 2017 | Volume: 48 | Issue: 8 | Pages: No page available

10.1161/strokeaha.117.017959 | PMID 28663513 Get It

Use of Fluorescent in Situ Hybridization for Deoxyribonucleic Acid Ploidy Analysis of Prostatic Adenocarcinoma
Persons, Diane L., Gibney, Donna J., Katzmann, Jerry A., Lieber, Michael M., Farrow, George M., Jenkins, Robert B.

Journal of Urology | June 30, 2017 | Volume: 150 | Issue: 1 | Pages: 120-125

10.1016/s0022-5347(17)35412-5 | PMID 8510232 Get It

Re: Radical Surgery for Advanced Prostate by, W. J. Catalona, J. Urol., 147: 916, 1992
Bergstralh, Erik J., Myers, Robert P.

Journal of Urology | June 30, 2017 | Volume: 149 | Issue: 6 | Pages: 1560-1560

10.1016/s0022-5347(17)36451-0 | PMID 8501814 Get It

Conservative Renal Surgery for Renal Cell Carcinoma in Von Hippel-Lindau’s Disease
Frydenberg, Mark , Malek, Reza S., Zincke, Horst

Journal of Urology | June 30, 2017 | Volume: 149 | Issue: 3 | Pages: 461-464

10.1016/s0022-5347(17)36119-0 | PMID 8437247 Get It

Appendiceal Mucinous Neoplasms: Diagnosis and Management
Shaib, Walid L. , Assi, Rita , Staley, Charles A., Memiş, Bahar , Adsay, Volkan , Bekaii‐Saab, Tanios , El‐Rayes, Bassel F. , Shamseddine, Ali I. , Alese, Olatunji B. , El-Rayes, Bassel F , Bekaii-Saab, Tanios S , Adsay, N Volkan

The Oncologist | June 30, 2017 | Volume: 22 | Issue: 9 | Pages: 1107-1116

10.1634/theoncologist.2017-0081 | PMID 28663356 Get It

Abstract Objective Appendiceal mucinous neoplasms (AMNs) are a rare and heterogeneous disease for which clinical management is challenging. We aim to review the literature regarding modalities of treatment to guide the management of AMNs. Methods and Review Criteria We conducted a PubMed search in February 2016 for English-language publications, using the terms “appendiceal,” “appendix,” “carcinoma,” “cancer,” “mucinous,” “treatment,” “genes,” “target,” “genomic,” and terms listed in the articles' subheadings. Published reports and abstracts from the American Society of Clinical Oncology meetings were also searched. Results In this review, we summarize current data and controversies in AMN classification, clinical presentation, molecular alterations, treatment outcomes with regard to cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and the role of systemic chemotherapy. Conclusion Appendiceal mucinous neoplasms are a heterogeneous group of tumors with a rising incidence. Treatment is based on stage and histology. Low-grade tumors are treated surgically with resection of the primary site in early stage disease, or peritoneal debulking and HIPEC in patients with advanced stage disease. Treatment of high-grade tumors requires further prospective trials, and options include debulking surgery and HIPEC with or without preoperative chemotherapy. Trials evaluating novel therapies based on the molecular profiling of AMN tumors are needed to evaluate therapeutic options in patients who are not surgical candidates.
Success of the Narrow-Backed Cuff Design of the AMS800 Artificial Urinary Sphincter: Analysis of 144 Patients
Leo, Mark E., Barrett, David M.

Journal of Urology | June 30, 2017 | Volume: 150 | Issue: 5 Part 1 | Pages: 1412-1414

10.1016/s0022-5347(17)35793-2 | PMID 8411412 Get It

The impact of incontinence etiology on artificial urinary sphincter outcomes
Miller, Adam R. , Linder, Brian J. , Rangel, Laureano J. , Yang, David Y. , Elliott, Daniel S. , Yang Md, David , Linder, Brian J

Investigative and Clinical Urology | June 30, 2017 | Volume: 58 | Issue: 4 | Pages: 241

10.4111/icu.2017.58.4.241 | PMID 28681033 Get It